Cardinal Health (CAH) just dropped over 7% after Q4 FY2025 results and a $1.9B Solaris Health acquisition. Is this a falling knife… or a setup for a smarter entry? In this episode, we break down the revenue miss, thin 3.53% gross margins, financing risk, DCF and PEG valuations, and my buy levels based on a net −6.5% near-term earnings impact.

Key points:

EPS/guidance up, but revenue miss + deal financing weigh on near-term earnings.

Thin gross margins amplify small revenue misses.

Staggered buy levels for better margin of safety.

If you found this useful, drop a like, comment your take on CAH’s Solaris deal, and subscribe for weekly “falling knife” breakdowns.

#stocks #CAH #CardinalHealth #stockmarket #earnings #valuation #DCF #investing #healthcare

Disclaimer: This video is for informational and entertainment purposes only and is not financial advice. Do your own research and consult a qualified advisor before investing.